100 related articles for article (PubMed ID: 27505074)
1. Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions.
Yao Z; Allen T; Oakley M; Samons C; Garrison D; Jansen B
Assay Drug Dev Technol; 2016 Aug; 14(6):355-63. PubMed ID: 27505074
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.
Gerami P; Yao Z; Polsky D; Jansen B; Busam K; Ho J; Martini M; Ferris LK
J Am Acad Dermatol; 2017 Jan; 76(1):114-120.e2. PubMed ID: 27707590
[TBL] [Abstract][Full Text] [Related]
3. Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy.
Ferris LK; Jansen B; Ho J; Busam KJ; Gross K; Hansen DD; Alsobrook JP; Yao Z; Peck GL; Gerami P
JAMA Dermatol; 2017 Jul; 153(7):675-680. PubMed ID: 28445578
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
[TBL] [Abstract][Full Text] [Related]
5. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.
Ferris LK; Gerami P; Skelsey MK; Peck G; Hren C; Gorman C; Frumento T; Siegel DM
Melanoma Res; 2018 Oct; 28(5):478-482. PubMed ID: 30004988
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma.
Ferris LK; Moy RL; Gerami P; Sligh JE; Jansen B; Yao Z; Cockerell CJ
J Invest Dermatol; 2019 May; 139(5):1127-1134. PubMed ID: 30500343
[TBL] [Abstract][Full Text] [Related]
7. Dermoscopic features associated with 3-GEP PLA: LINC00518, PRAME, and TERT expression in suspicious pigmented lesions.
Ludzik J; Becker AL; Latour E; Lee C; Witkowski A
Skin Res Technol; 2023 Apr; 29(4):e13323. PubMed ID: 37083005
[TBL] [Abstract][Full Text] [Related]
8. Non-Invasive Gene Expression Testing to Rule Out Melanoma.
Rivers JK; Copley MR; Svoboda R; Rigel DS
Skin Therapy Lett; 2018 Sep; 23(5):1-4. PubMed ID: 30248161
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma.
Halait H; Demartin K; Shah S; Soviero S; Langland R; Cheng S; Hillman G; Wu L; Lawrence HJ
Diagn Mol Pathol; 2012 Mar; 21(1):1-8. PubMed ID: 22306669
[TBL] [Abstract][Full Text] [Related]
10. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma.
Tian Y; Zhang X; Hao Y; Fang Z; He Y
Melanoma Res; 2014 Aug; 24(4):335-41. PubMed ID: 24892958
[TBL] [Abstract][Full Text] [Related]
11. Technological advances for the detection of melanoma: Advances in molecular techniques.
Fried L; Tan A; Bajaj S; Liebman TN; Polsky D; Stein JA
J Am Acad Dermatol; 2020 Oct; 83(4):996-1004. PubMed ID: 32360759
[TBL] [Abstract][Full Text] [Related]
12. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.
Gibbs P; Hutchins AM; Dorian KT; Vaughan HA; Davis ID; Silvapulle M; Cebon JS
Melanoma Res; 2000 Jun; 10(3):259-64. PubMed ID: 10890380
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.
Sakurai E; Maesawa C; Shibazaki M; Yasuhira S; Oikawa H; Sato M; Tsunoda K; Ishikawa Y; Watanabe A; Takahashi K; Akasaka T; Masuda T
Int J Oncol; 2011 Sep; 39(3):665-72. PubMed ID: 21687938
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
15. TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi.
You Y; Wang SH; Zhang JF; Zheng SY
Melanoma Res; 2012 Dec; 22(6):430-5. PubMed ID: 23047161
[TBL] [Abstract][Full Text] [Related]
16. Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study.
Cazzato G; Mangialardi K; Falcicchio G; Colagrande A; Ingravallo G; Arezzo F; Giliberti G; Trilli I; Loizzi V; Lettini T; Scarcella S; Annese T; Parente P; Lupo C; Casatta N; Maiorano E; Cormio G; Resta L; Ribatti D
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328098
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
[TBL] [Abstract][Full Text] [Related]
18. Droplet digital PCR (ddPCR) vs quantitative real-time PCR (qPCR) approach for detection and quantification of Merkel cell polyomavirus (MCPyV) DNA in formalin fixed paraffin embedded (FFPE) cutaneous biopsies.
Arvia R; Sollai M; Pierucci F; Urso C; Massi D; Zakrzewska K
J Virol Methods; 2017 Aug; 246():15-20. PubMed ID: 28414163
[TBL] [Abstract][Full Text] [Related]
19. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
20. Development of a Quantitative Real-Time RT-PCR Assay for the Detection of MAGE-A3-Positive Tumors.
Gruselle O; Coche T; Louahed J
J Mol Diagn; 2015 Jul; 17(4):382-91. PubMed ID: 25986000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
